← Leaderboards
John W Babich
Biostream Therapeutics, Inc.
$3,321,217
Attributed
$3,440,079
Total exposure
10
Grants
2
Lead (contact PI)
Attributed= this PI's even-split share of every grant they're on (the fair, additive number). Exposure = full size of all those grants.
Funding over time
peak $737.5K · FY2005–20$1M$750K$500K$250K$0
'05
'06
'07
'08
'09
'10
'11
'12
'13
'14
'15
'16
'17
'18
'19
'20
Funding mix
By agency
NIH$3,440,079 · 10
By mechanism
R44$1,520,819 · 1
R43$1,275,640 · 7
R21$643,620 · 2
Top collaborators
- James Kelly1 shared
Others in their field
Top investigators on “Technology /Technique Development”
- Eric S Lander · Whitehead Institute For Biomedical Res$242,268,294
- Richard K. Wilson · Washington University$145,541,485
- Robert H Waterston · Washington University$144,225,057
- Ronald Wayne Davis · Stanford University$43,786,494
- Andrzej Joachimiak Joachimiak · University Of Chicago$33,231,516
- Deirdre R. Meldrum · University Of Washington$26,048,264
Research focus
Technology /Technique DevelopmentUptakeImageRadiotracerMonitorAnalogProceduresMalignant NeoplasmsProgramsIn VitroAnimalsMetabolicMouse ModelPre-ClinicalBloodLabelClinicChemical SynthesisClinical TrialsBaseGenerationsBioimaging /Biomedical ImagingBiomarkerCells
Grant awards (13)
PET Imaging Biomarkers to Predict Cardiac Remodeling and Functional Decline in Cardiotoxicity Arising from Chemotherapy$237,724
R21 · FY2020 · CA
Radiolabeled FASN Inhibitors for PET Imaging$176,883
R21 · FY2018 · CA · contact PI
Radiolabeled FASN Inhibitors for PET Imaging$229,013
R21 · FY2017 · CA · contact PI
Early Clinical Testing for Melanin Targeting Radio-therapeutic agent in melanoma$737,540
R44 · FY2011 · CA · contact PI
Early Clinical Testing for Melanin Targeting Radio-therapeutic agent in melanoma$559,294
R44 · FY2010 · CA · contact PI
Early Clinical Testing for Melanin Targeting Radio-therapeutic agent in melanoma$223,985
R44 · FY2009 · CA · contact PI
An Instant Kit for 2-[18F]Fluoro-2-deoxyglucose (FDG)$130,387
R43 · FY2005 · EB
Labeled inhibitors for angiotensin converting enzyme$337,713
R43 · FY2004 · HL
Novel glutamate conjugates for radiotargeting PSMA$327,235
R43 · FY2004 · EB
Novel Tc(I) Technetium-99m Labeled Fatty Acid analogs$185,363
R43 · FY2002 · HL
POLYMERIC MICELLAR CONTRAST AGENTS FOR CT ANGIOGRAPHY$98,742
R43 · FY2000 · HL
TC-99M ADENINE NUCLEOTIDE POLYPHOSPHATE IMAGING AGENTS$98,125
R43 · FY2000 · CA
TECHNETIUM-99M LABELED FATTY ACID ANALOGS FOR IMAGING$98,075
R43 · FY2000 · HL